249 related articles for article (PubMed ID: 35341691)
1. Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome.
Beraud M; Hashami SA; Lozano M; Bah A; Keith P
Transfus Apher Sci; 2022 Aug; 61(4):103433. PubMed ID: 35341691
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plasma exchange in the treatment of COVID-19 induced cytokine storm: the first Moroccan experience.
Bouayed MZ; Laaribi I; Benaini I; Yeznasni A; Berrajaa S; Oujidi Y; Bkiyar H; Abda N; Housni B
BMC Infect Dis; 2023 Nov; 23(1):829. PubMed ID: 38007416
[TBL] [Abstract][Full Text] [Related]
3. The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: a meta-analysis.
Wardhani SO; Fajar JK; Soegiarto G; Wulandari L; Maliga HA; Ilmawan M; Merysa R; Simamora AB; Aini Q; Noviantari K; Lestari AW; Harnila MY; Syafi'i I; Djianzonie JAC; Siagian N; Nining S; Hanim RZ; Wahyuni W; Aulia F; Juliansyah J; Mahmud R; Tamara F; Mahendra AI; Wowor AC; Baladraf F; Hadinata PH; Ikkeputri A; Nadya H; Kartini DA; Husnah M; Nainu F; Harapan H
F1000Res; 2021; 10():1280. PubMed ID: 35083038
[No Abstract] [Full Text] [Related]
4. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.
Gluck WL; Callahan SP; Brevetta RA; Stenbit AE; Smith WM; Martin JC; Blenda AV; Arce S; Edenfield WJ
Respir Med; 2020 Dec; 175():106188. PubMed ID: 33190086
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic plasma exchange in a critically ill Covid-19 patient.
Altmayer V; Saheb S; Rohaut B; Marois C; Cao A; Gallo A; Le Guennec L; Weiss N; Demeret S
J Clin Apher; 2021 Feb; 36(1):179-182. PubMed ID: 32875601
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma exchange: A potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection.
Al-Hashami S; Khamis F; Al-Yahyay M; Al-Dowaiki S; Al-Mashaykhi L; Al-Khalili H; Chandwani J; Al-Salmi I; Al-Zakwani I
J Clin Apher; 2022 Dec; 37(6):563-572. PubMed ID: 36102158
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Therapeutic Plasma Exchange on Inflammatory Markers and Acute Phase Reactants in Patients with Severe SARS-CoV-2 Infection.
Porosnicu TM; Sirbu IO; Oancea C; Sandesc D; Bratosin F; Rosca O; Jipa D; Boeriu E; Bandi SSS; Pricop M
Medicina (Kaunas); 2023 Apr; 59(5):. PubMed ID: 37241099
[No Abstract] [Full Text] [Related]
9. Efficacy of Therapeutic Plasma Exchange in Severe Acute Respiratory Distress Syndrome in COVID-19 Patients from the Western Part of Romania.
Porosnicu TM; Gindac C; Popovici S; Marinescu A; Jipa D; Lazaroiu V; Sandesc D; Oancea C; Folescu R; Zamfir AS; Zamfir CL; Nussbaum LA; Sirbu IO
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556909
[TBL] [Abstract][Full Text] [Related]
10. Use of therapeutic plasma exchange in COVID-19: A systematic review of current evidence.
Carlson N; Szpirt WM
Ther Apher Dial; 2022 Dec; 26 Suppl 1(Suppl 1):3-11. PubMed ID: 36468346
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic plasma exchange in adults with severe COVID-19 infection.
Khamis F; Al-Zakwani I; Al Hashmi S; Al Dowaiki S; Al Bahrani M; Pandak N; Al Khalili H; Memish Z
Int J Infect Dis; 2020 Oct; 99():214-218. PubMed ID: 32585284
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
13. Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices.
Patidar GK; Land KJ; Vrielink H; Rahimi-Levene N; Dann EJ; Al-Humaidan H; Spitalnik SL; Dhiman Y; So-Osman C; Hindawi SI
Vox Sang; 2021 Aug; 116(7):798-807. PubMed ID: 33730761
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients.
Tabibi S; Tabibi T; Conic RRZ; Banisaeed N; Streiff MB
J Intensive Care Med; 2020 Sep; 35(9):827-835. PubMed ID: 32666875
[TBL] [Abstract][Full Text] [Related]
15. Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives.
Memish ZA; Faqihi F; Alharthy A; Alqahtani SA; Karakitsos D
Int J Antimicrob Agents; 2021 Feb; 57(2):106273. PubMed ID: 33370568
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study.
Kamran SM; Mirza ZE; Naseem A; Liaqat J; Fazal I; Alamgir W; Saeed F; Saleem S; Nisar S; Yousaf MA; Khan AZ; Hussain M; Azam R; Hussain M; Khan KA; Jamal Y; Iftikhar R
PLoS One; 2021; 16(1):e0244853. PubMed ID: 33411791
[TBL] [Abstract][Full Text] [Related]
17. Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report.
Faqihi F; Alharthy A; Alshaya R; Papanikolaou J; Kutsogiannis DJ; Brindley PG; Karakitsos D
BMC Cardiovasc Disord; 2020 Aug; 20(1):389. PubMed ID: 32842957
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial.
Faqihi F; Alharthy A; Abdulaziz S; Balhamar A; Alomari A; AlAseri Z; Tamim H; Alqahtani SA; Kutsogiannis DJ; Brindley PG; Karakitsos D; Memish ZA
Int J Antimicrob Agents; 2021 May; 57(5):106334. PubMed ID: 33838224
[TBL] [Abstract][Full Text] [Related]
19. Application of extracorporeal therapies in critically ill COVID-19 patients.
Zhou Z; Kuang H; Ma Y; Zhang L
J Zhejiang Univ Sci B; 2021 Sept 15; 22(9):701-717. PubMed ID: 34514751
[TBL] [Abstract][Full Text] [Related]
20. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
Brikman S; Bieber A; Dori G
Isr Med Assoc J; 2020 Aug; 22(8):505-513. PubMed ID: 33236584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
